|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 208.26 USD | +0.66% |
|
-2.22% | +1.09% |
| 08:07pm | Argus Research Adjusts Cardinal Health Price Target to $232 From $211, Maintains Buy Rating | MT |
| 01-22 | Escalate, De-Escalate, Repeat |  |
| Capitalization | 49.16B 41.81B 38.75B 36.21B 67.51B 4,516B 71.55B 443B 176B 2,132B 184B 181B 7,757B | P/E ratio 2026 * |
25.9x | P/E ratio 2027 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise value | 52.87B 44.97B 41.68B 38.95B 72.61B 4,857B 76.96B 476B 189B 2,293B 198B 194B 8,343B | EV / Sales 2026 * |
0.2x | EV / Sales 2027 * | 0.18x |
| Free-Float |
89.22% | Yield 2026 * |
1% | Yield 2027 * | 1.01% |
More valuation ratios
* Estimated data
More news
Last Transcript: Cardinal Health, Inc.
More recommendations
More press releases
More news
| 1 day | +0.68% | ||
| 1 week | -2.22% | ||
| Current month | +1.09% | ||
| 1 month | +0.18% | ||
| 3 months | +30.52% | ||
| 6 months | +31.68% | ||
| Current year | +1.09% |
| 1 week | 206.27 |  | 213.38 |
| 1 month | 199.94 | | 215.48 |
| Current year | 199.94 | | 215.48 |
| 1 year | 120.72 | | 215.48 |
| 3 years | 68.53 | | 215.48 |
| 5 years | 45.85 | | 215.48 |
| 10 years | 39.05 | | 215.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 53 | 01/09/2022 |
Aaron Alt
DFI | Director of Finance/CFO | 55 | 10/02/2023 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gregory Kenny
CHM | Chairman | 73 | 01/11/2018 |
| Director/Board Member | 73 | 12/09/2013 | |
Nancy Killefer
BRD | Director/Board Member | 71 | 14/09/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.66% | -2.22% | +60.67% | +175.23% | 49.16B | |
| -0.58% | -3.53% | +35.77% | +116.19% | 101B | |
| +1.32% | +6.99% | - | - | 23.74B | |
| -0.24% | -3.11% | +9.47% | -22.96% | 9.48B | |
| +0.98% | -0.34% | -10.22% | -6.72% | 8.32B | |
| +0.97% | +1.76% | +2.46% | +7.66% | 8.24B | |
| +2.71% | -2.06% | +11.45% | +77.07% | 6.73B | |
| -0.67% | -1.37% | +21.72% | +30.75% | 6.15B | |
| +5.08% | +3.33% | +12.27% | +9.92% | 3.8B | |
| Average | +1.09% | +0.24% | +17.95% | +48.39% | 24.05B | |
| Weighted average by Cap. | +0.24% | -1.59% | +35.66% | +108.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 259B 220B 204B 191B 355B 23,779B 377B 2,332B 926B 11,227B 970B 951B 40,841B | 280B 239B 221B 207B 385B 25,764B 408B 2,526B 1,003B 12,165B 1,052B 1,030B 44,250B |
| Net income | 1.92B 1.63B 1.51B 1.41B 2.64B 176B 2.8B 17.3B 6.87B 83.32B 7.2B 7.05B 303B | 2.07B 1.76B 1.63B 1.52B 2.84B 190B 3.01B 18.64B 7.4B 89.75B 7.76B 7.6B 326B |
| Net Debt | 3.71B 3.16B 2.93B 2.74B 5.1B 341B 5.4B 33.45B 13.28B 161B 13.92B 13.64B 586B | 2.26B 1.92B 1.78B 1.67B 3.11B 208B 3.29B 20.38B 8.09B 98.11B 8.48B 8.31B 357B |
More financial data
* Estimated data
Employees
55,392
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 207.92 $ | +0.50% | 735,578 |
| 22/01/26 | 206.89 $ | -0.76% | 1,742,690 |
| 21/01/26 | 208.47 $ | -0.90% | 1,849,898 |
| 20/01/26 | 210.37 $ | -0.98% | 1,654,240 |
| 16/01/26 | 212.45 $ | -0.47% | 1,331,389 |
Delayed Quote Nyse, January 23, 2026 at 09:37 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
206.89USD
Average target price
226.93USD
Spread / Average Target
+9.69%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CAH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition